Guido J. Neels - Jun 1, 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/Guido Neels
Stock symbol
AXGN
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 05:12 PM
Previous filing
Jun 7, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +6.17K +14.49% $0.00 48.8K Jun 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -6.17K -100% $0.00* 0 Jun 1, 2021 Common Stock 6.17K Direct F1, F2
transaction AXGN Stock Option (right to purchase) Award $0 +6.03K $0.00 6.03K Jun 1, 2021 Common Stock 6.03K $19.76 Direct F3
transaction AXGN Restricted Stock Units Award $0 +3.04K $0.00 3.04K Jun 1, 2021 Common Stock 3.04K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 This reflects the number of restricted stock units that became vested as of June 1, 2021.
F3 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.